Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Pond, Gregory P.
503  Ergebnisse:
Personensuche X
?
1

Cancer-specific mortality in multiple myeloma: a population..:

McCurdy, Arleigh ; Seow, Hsien ; Pond, Gregory P....
Haematologica.  108 (2023)  12 - p. 3384-3391 , 2023
Link: https://doi.org/10.3324/..
 
?
2

Impact of Angiotensin Converting Enzyme Inhibitors on Patho..:

Skelton IV, William Paul ; Masur, Jack ; Thomas, Jonathan...
Clinical Genitourinary Cancer.  22 (2024)  5 - p. 102143 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Does the number of 6-monthly adjuvant zoledronate infusions..:

Beltran-Bless, Ana-Alicia ; Clemons, Mark J. ; Fesl, Christian...
European Journal of Cancer.  180 (2023)  - p. 108-116 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Neurocognitive impairment, neurobehavioral symptoms, fatigu..:

Sekely, Angela ; Bernstein, Lori J ; Campbell, Kristin L...
Neuro-Oncology Practice.  10 (2022)  1 - p. 89-96 , 2022
Link: https://doi.org/10.1093/..
 
?
5

Optimal pathological response after neoadjuvant chemotherap..:

Ravi, Praful ; Pond, Gregory R. ; Diamantopoulos, Leonidas N....
BJU International.  128 (2021)  5 - p. 607-614 , 2021
Link: https://doi.org/10.1111/..
 
?
6

Circulating Tumor DNA Alterations in Advanced Urothelial Ca..:

Grivas, Petros ; Lalani, Aly-Khan A. ; Pond, Gregory R....
European Urology Oncology.  3 (2020)  5 - p. 695-699 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Cabozantinib for Progressive Metastatic Castration-resistan..:

Sonpavde, Guru P. ; Pond, Gregory R. ; Fizazi, Karim...
European Urology Oncology.  3 (2020)  4 - p. 540-543 , 2020
Link: https://doi.org/10.1016/..
 
?
8

High triple‐negative breast cancer prevalence and aggressiv..:

Hercules, Shawn M. ; Hercules, Jevon C. ; Ansari, Amna...
Cancer.  126 (2020)  10 - p. 2217-2224 , 2020
Link: https://doi.org/10.1002/..
 
?
9

Seamless Designs: Current Practice and Considerations for E..:

Hobbs, Brian P ; Barata, Pedro C ; Kanjanapan, Yada...
JNCI: Journal of the National Cancer Institute.  111 (2018)  2 - p. 118-128 , 2018
Link: https://doi.org/10.1093/..
 
?
10

Association Between RECIST Changes and Survival in Patients..:

Sonpavde, Guru ; Pond, Gregory R. ; Templeton, Arnoud J....
European Urology.  69 (2016)  6 - p. 980-983 , 2016
Link: https://doi.org/10.1016/..
 
?
11

Concurrent Chemoradiotherapy for Men With Locally Advanced ..:

Pond, Gregory R. ; Milowsky, Matthew I. ; Kolinsky, Michael P....
Clinical Genitourinary Cancer.  12 (2014)  6 - p. 440-446 , 2014
Link: https://doi.org/10.1016/..
 
?
12

Prognostic risk stratification derived from individual pati..:

Pond, Gregory R. ; Di Lorenzo, Giuseppe ; Necchi, Andrea...
Urologic Oncology: Seminars and Original Investigations.  32 (2014)  4 - p. 501-508 , 2014
Link: https://doi.org/10.1016/..
 
?
13

Time from Prior Chemotherapy Enhances Prognostic Risk Group..:

Sonpavde, Guru ; Pond, Gregory R. ; Fougeray, Ronan...
European Urology.  63 (2013)  4 - p. 717-723 , 2013
Link: https://doi.org/10.1016/..
 
?
14

Statistical and analytical approaches for assessing biomark..:

Henderson, Matthew P.A. ; Pond, Gregory R. ; Kavsak, Peter A.
Clinical Biochemistry.  45 (2012)  3 - p. 187-188 , 2012
Link: https://doi.org/10.1016/..
 
?
15

Expanded phase II trial of gemcitabine and capecitabine for..:

Riechelmann, Rachel P. ; Townsley, Carol A. ; Chin, Sheray N...
Cancer.  110 (2007)  6 - p. 1307-1312 , 2007
Link: https://doi.org/10.1002/..
 
1-15